Skip to content

Drug interactions

Efavirenz + Saxagliptin

Severity: Minor

Efavirenz and Saxagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz, a CYP3A4 inducer, may reduce saxagliptin and its active metabolite exposure. A clinically important loss of glucose-lowering effect is not expected from this interaction.

What this interaction means in plain words

Efavirenz and Saxagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Efavirenz belongs to Anti Virals; Saxagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Efavirenz induces CYP3A4/5, which metabolizes saxagliptin to its active metabolite and clears the parent drug.

What to do

No dose change is routinely required. Monitor glycemic control when efavirenz is started or stopped.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Saxagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Saxagliptin?

MediHelp rates the interaction as minor. Efavirenz and Saxagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Efavirenz, a CYP3A4 inducer, may reduce saxagliptin and its active metabolite exposure. A clinically important loss of glucose-lowering effect is not expected from this interaction.

How serious is the interaction between Efavirenz and Saxagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is routinely required. Monitor glycemic control when efavirenz is started or stopped.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in